Novel Drug Combination Shows Promise for Advanced HER2-Negative Breast Cancer
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel
The Research Navigator’s Corner- January 2024
The Research Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple
Johns Hopkins Medicine-Led Study Shows Rapid COVID-19 Tests Done at Home Are Reliable
Findings from recent investigation suggest physicians can feel confident prescribing treatment based on results from patient-reported, self-administered tests In a study involving nearly 1,000 patients
Johns Hopkins Researchers Make Progress Toward Developing Blood Tests for Psychiatric and Neurological Disorders
Researchers used genetic markers in maternal blood that serve as “stand-ins” for brain molecules Researchers in a Johns Hopkins Children’s Center-led study that used genetic
Funding Opportunity: Accelerated Translational Incubator Pilot (ATIP) Program
Application Deadline: Monday, March 11, 2024 | 5:00 pm EST Request for Applications The milestone driven Accelerated Translational Incubator Pilot (ATIP) Program provides awards ranging in
ICTR in the News: Johns Hopkins Children’s Center Study Finds Cost-Driven Housing Moves Lead to Disruptions in Federal Assistance Programs
This article discusses the work of Jacky Jennings, PhD, MPH, BIRCWH Award program mentor. Across the United States, a growing number of families with low
Combination Drug Therapy Shows Promise for a Treatment-Resistant Cancer
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) — soft tissue tumors that are stubbornly resistant to
International Consortium Identifies Biomarkers That Improve Prediction Accuracy of Cardiovascular Disease Risk in People with Type 2 Diabetes
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes.
Retinal Photoreceptors Use Dual Pathways to Tell Brain ‘I’ve Seen the Light!’
Johns Hopkins neuroscientists show how specialized cells signal the presence of light simultaneously in two distinct ways Working with mammalian retinal cells, neuroscientists at Johns
Funding Opportunities: Fisher Center for Environmental Infectious Diseases
Letter of Intent Deadline: Friday, February 9, 2024 Application Deadline: Friday, March 1, 2024 The Fisher Center for Environmental Infectious Diseases, through the continued
Study Finds AI–Driven Eye Exams Increase Screening Rates for Youth with Diabetes
Johns Hopkins Children’s Center investigators say AI-driven cameras that take images of the back of the eye and require no eye drops can be used
Natural Compounds Derived from Soy and Other Plants Reduce Breast Cancer Recurrence and Improve Survival, Research Shows
Credit: Adobe Stock Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death,
Community Cancer Care Linked with Poorer Outcomes for Some HeadNeck Cancers
Getty Images Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward
Study Identifies “Visual System” Protein for Circadian Rhythm Stability
Teneurin-3 appears to help wire the brain in mice to resist changes in sleep and other cycles linked to changing light Credit: Getty Images Scientists
